Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.5950 (1.9%) ($8.5950 - $8.5950) on Tue. May. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.37% (three month average) | RSI | 74 | Latest Price | $8.5950(1.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.9% a day on average for past five trading days. | Weekly Trend | BCRX advances 7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(31%) CEMB(27%) XLRE(25%) BND(23%) BWX(22%) | Factors Impacting BCRX price | BCRX will decline at least -1.685% in a week (0% probabilities). VIXM(-17%) VXX(-16%) UUP(-13%) TLT(-11%) VCIT(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.685% (StdDev 3.37%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.47(1.48%) | 10 Day Moving Average | $8.02(7.17%) | 20 Day Moving Average | $7.89(8.94%) | To recent high | -16.9% | To recent low | 16.5% | Market Cap | $1.516b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |